Search results
Showing 901 to 950 of 8215 results
Percutaneous ultrasound-guided microwave ablation for symptomatic benign thyroid nodules (IPG743)
Evidence-based recommendations on percutaneous ultrasound-guided microwave ablation for symptomatic benign thyroid nodules. This involves using microwaves from a wire inserted into the nodule to heat and destroy it (ablation).
View recommendations for IPG743Show all sections
NICE recommends adapted shoes for people with severe osteoarthritis
People with osteoarthritis who are eligible for knee surgery could be offered specially adapted shoes to help with their painful and stiff knees following a draft recommendation by NICE.
Helping to prevent winter deaths and illnesses associated with cold homes
A quick guide for home care managers on preventing deaths and illnesses associated with cold homes.
Extracorporeal shockwave therapy for calcific tendinopathy in the shoulder (IPG742)
Evidence-based recommendations on extracorporeal shockwave therapy for calcific tendinopathy in the shoulder. This involves placing a device on the skin that delivers short pulses of sound into the shoulder. The aim is to reduce pain and improve shoulder function.
View recommendations for IPG742Show all sections
Advocacy services for adults with health and social care needs (NG227)
This guideline covers advocacy for people using health and social care services in all adult settings (including young people under 18 using adult services). It describes how to commission and deliver effective advocacy, as well as identifying who should be offered advocacy (including who is legally entitled to it). It also covers monitoring and improving advocacy services, and training and skills for advocates and practitioners.
NICE final draft guidance adds further treatment option for triple-negative breast cancer
NICE has today (8 November 2022) published final draft guidance which recommends pembrolizumab as an option for people with a type of breast cancer called triple-negative breast cancer.
At NICE, we balance best care with value for money, helping you to improve service quality and achieve the best health outcomes for the communities you serve.
Recommendation ID IPG741/01 Question Evidence on the safety and efficacy of YAG laser vitreolysis for symptomatic vitreous floaters is
Recommendation ID NG226/07 Question Electroacupuncture: Is electroacupuncture a clinically and cost-effective treatment for any subgroup
Recommendation ID IPG740/01 Question The evidence for treating an acute migraine attack is adequate but, for treating subsequent attacks
Recommendation ID NG226/12 Question Referral criteria for joint replacement: What are the most important indicators that someone with osteoarthritis
Recommendation ID NG226/05 Question Patient information: - What information on the management of flares do people with osteoarthritis
Recommendation ID NG226/01 Question Exercise: What is the clinical and cost effectiveness of supervised group and individual exercise compared
Recommendation ID NG226/10 Question Topical and oral medicines:- What is the clinical and cost effectiveness of topical local anaesthetics
Recommendation ID NG226/03 Question Topical medicines: What is the clinical and cost effectiveness of topical non-steroidal anti-inflammatory
Recommendation ID NG226/06 Question Manual therapy: What is the clinical and cost effectiveness of manual therapy for people with osteoarthritis
Recommendation ID NG226/04 Question Follow-up strategies: What is the clinical and cost effectiveness of patient-initiated follow-up compared
Recommendation ID NG226/02 Question Devices: What is the clinical and cost effectiveness of devices compared with usual care for the management
Recommendation ID NG226/08 Question Extracorporeal shockwave therapy: What is the clinical and cost effectiveness of extracorporeal shockwave
Recommendation ID NG226/09 Question Footwear: What is the clinical and cost effectiveness of footwear for managing lower limb osteoarthritis
Recommendation ID NG226/13 Question Imaging for management of osteoarthritis:- What is the clinical and cost effectiveness of imaging for
Recommendation ID NG226/11 Question Intra-articular injections:- What is the clinical and cost effectiveness of intra-articular corticosteroids
Draft guidance released for consultation today (Friday 4th Nov) states the technologies can be used with support from a mental health professional, while further evidence is generated to check if the benefits they offer are realised in practice.
Towards a new partnership – NICE and the voluntary and community sector
Victoria Thomas gives details of NICE’s new voluntary and community sector forum, which brings together a range of organisations, including health and care sector charities and not for profit groups, and gives them an opportunity to share their views and help shape NICE’s work in the future
NICE quality improvement resource (QIR) for adult social care
Whether you are a researcher, funder, charity or policy organisation, you can partner with us for methodological research. As one of the leading...
NICE is unable to make a recommendation on slow-release potassium bicarbonate–potassium citrate (Sibnayal) for treating distal renal tubular acidosis in people 1 year and over. This is because Advicenne withdrew its evidence submission. We will review this decision if the company decides to make a submission.
Show all sections
Sections for TA838
The guidance development timeline
NICE has developed a medtech innovation briefing (MIB) on digital technologies for the detection of melanoma .
Ventripoint Medical System Plus for measuring heart volume and function (MIB310)
February 2023: The medtech innovation briefing on Ventripoint Medical System Plus for measuring heart volume and function has been withdrawn as the company have withdrawn from the process.
Professor Michael Peake September 2019 In England the average 5-year survival rate for people diagnosed with lung cancer between 1991 and 1993 was 5%
How people can have an impact on NICE guidance
Provider name: Oxford University Press Lot details Lot 1 - Electronic Journals, Electronic Books, Databases Provider helpdesk
The section of the NICEimpact lung cancer report looking at how lung cancer can be prevented.
The section of the NICE impact lung cancer report looking at how lung cancer is detected.
The section of the NICE impact lung cancer report looking at the diagnosis and staging process of lung cancer care.
The section of the NICE impact lung cancer report looking at how the disease is treated.
The section of the NICE impact lung cancer report looking at how patients are treated during their care.
Part of NICEimpact maternity and neonatal care Previous: Updates from our last maternity report Next: Specialist care of newborns
Part of NICEimpact maternity and neonatal care Previous: Maternity and mental health Next: Spotlight on valproate prescribing
Part of NICEimpact maternity and neonatal care Previous: Spotlight on valproate prescribing Dr Kathryn Gutteridge, President of
Part of NICEimpact maternity and neonatal care Previous: Specialist care of newborns Next: Commentary Babies exposed to
Throughout this report we have highlighted examples showing how uptake of our guidance has contributed to improvements in arthritis care. Improvements
NICE's impact on managing long-term conditions in children in the community
NICE recommends that all children, young people and adults with a learning disability should be offered an annual physical health check
NICE's impact on innovative medicines for childhood conditions
Commentary by Professor Russell Viner from the Royal College of Paediatrics and Child Health
NICE's impact on preventing or delaying the onset of dementia
NICE's impact on dementia referral, diagnosis and care planning
NICE's impact on hospital stays, delays in leaving hospital and independent living